Welcome to LookChem.com Sign In|Join Free
  • or
[2-(4-METHOXY-PHENYL)-ETHYL]-METHYL-AMINE is an alkaloid compound that has been recently discovered in a Coryphantha species, specifically C. bumamma. It is characterized by its unique chemical structure, which includes a 4-methoxy-phenyl group attached to an ethyl chain and a methyl-amine group.

4091-50-3

Post Buying Request

4091-50-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4091-50-3 Usage

Uses

Unfortunately, the provided materials do not offer specific information on the uses of [2-(4-METHOXY-PHENYL)-ETHYL]-METHYL-AMINE. However, given that it is an alkaloid, it is possible that it may have potential applications in various industries, such as pharmaceuticals, agriculture, or as a chemical intermediate. Further research and development would be required to determine its specific uses and benefits.

References

Bruhn et al., Acta Pharm. Suec., 12, 199 (1975)

Check Digit Verification of cas no

The CAS Registry Mumber 4091-50-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,0,9 and 1 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4091-50:
(6*4)+(5*0)+(4*9)+(3*1)+(2*5)+(1*0)=73
73 % 10 = 3
So 4091-50-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO/c1-11-8-7-9-3-5-10(12-2)6-4-9/h3-6,11H,7-8H2,1-2H3

4091-50-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name compound 48/80

1.2 Other means of identification

Product number -
Other names N-Methyl 4-Methoxyphenethylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4091-50-3 SDS

4091-50-3Synthetic route

ethyl-N-<2-(4-methoxyphenyl)ethyl>-carbamate
136390-01-7

ethyl-N-<2-(4-methoxyphenyl)ethyl>-carbamate

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran Heating;99%
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 50℃; Inert atmosphere;27%
2-4-methoxyphenylethylcarbamic acid methyl ester
91247-71-1

2-4-methoxyphenylethylcarbamic acid methyl ester

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 0℃; Reflux;93%
With lithium aluminium tetrahydride
methylamine
74-89-5

methylamine

1-(2-Chloroethyl)-4-methoxybenzene
18217-00-0

1-(2-Chloroethyl)-4-methoxybenzene

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
In methanol for 168h; Ambient temperature;73%
Stage #1: methylamine; 1-(2-Chloroethyl)-4-methoxybenzene In ethanol at 20℃; for 1h;
Stage #2: With triisobutylaluminum In ethanol at 60℃; for 24h;
72%
methylamine
74-89-5

methylamine

4-methoxyphenylacetylen
768-60-5

4-methoxyphenylacetylen

A

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

B

4-methoxy-N-methyl-α-methylbenzylamine
41684-13-3

4-methoxy-N-methyl-α-methylbenzylamine

Conditions
ConditionsYield
Stage #1: methylamine; 4-methoxyphenylacetylen; Ind2TiMe2 In toluene at 80℃; under 760 Torr; for 7h;
Stage #2: With sodium cyanoborohydride; zinc(II) chloride In methanol; toluene at 25℃; for 16h;
A 20%
B 19%
benzaldehyde
100-52-7

benzaldehyde

4-Methoxyphenethylamine
55-81-2

4-Methoxyphenethylamine

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
anschliessend mit Dimethylsulfat und dann mit wss. Aethanol;
4-methoxyphenethyl bromide
14425-64-0

4-methoxyphenethyl bromide

methylamine
74-89-5

methylamine

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
With methanol at 100℃;
2-(4-methoxyphenyl)-N-methylacetamide
59907-36-7

2-(4-methoxyphenyl)-N-methylacetamide

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran
With borane-THF In tetrahydrofuran for 4h; Inert atmosphere; Reflux;
N-[2-(4-methoxyphenyl)ethyl]formamide
56100-69-7

N-[2-(4-methoxyphenyl)ethyl]formamide

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran
4-Methoxyphenethylamine
55-81-2

4-Methoxyphenethylamine

4-Nitrophenyl chloroformate
7693-46-1

4-Nitrophenyl chloroformate

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
With 4-methyl-morpholine; lithium aluminium tetrahydride; N-ethyl-N,N-diisopropylamine; Wang resin 1.) 0 deg C, 2 h; room temp., overnight, 2.) DMF, room temp., overnight, 3.) THF, 60 deg C, 14 h; Yield given. Multistep reaction;
4-methoxyphenyl magnesium bromide
13139-86-1

4-methoxyphenyl magnesium bromide

methyl-<2-chloro-ethyl>-amine hydrochloride

methyl-<2-chloro-ethyl>-amine hydrochloride

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

2-(4-Methoxyphenyl)ethanol
702-23-8

2-(4-Methoxyphenyl)ethanol

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: SOCl2 / 0.5 h / Heating
2: 73 percent / methanol / 168 h / Ambient temperature
View Scheme
Multi-step reaction with 2 steps
1.1: phosphorus pentachloride; calcium carbonate / toluene / 3.67 h / 0 - 20 °C / Inert atmosphere
2.1: ethanol / 1 h / 20 °C
2.2: 24 h / 60 °C
View Scheme
4-Methoxyphenethylamine
55-81-2

4-Methoxyphenethylamine

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 99 percent / K2CO3 / tetrahydrofuran / 25 °C
2: 99 percent / LiAlH4 / tetrahydrofuran / Heating
View Scheme
Multi-step reaction with 2 steps
1: Et3N / CHCl3
2: LiAlH4 / tetrahydrofuran
View Scheme
Multi-step reaction with 2 steps
1: pyridine / dichloromethane / 0 - 20 °C
2: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 50 °C / Inert atmosphere
View Scheme
1-methoxy-4-(2-nitro-vinyl)-benzene
3179-10-0

1-methoxy-4-(2-nitro-vinyl)-benzene

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: (catalytic hydrogenation)
2: Et3N / CHCl3
3: LiAlH4 / tetrahydrofuran
View Scheme
4-methoxyphenyl-acetic chloride
4693-91-8

4-methoxyphenyl-acetic chloride

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: toluene; water / 0.5 h / 0 - 22 °C / Inert atmosphere
2: borane-THF / tetrahydrofuran / 4 h / Inert atmosphere; Reflux
View Scheme
4-Methoxyphenylacetic acid
104-01-8

4-Methoxyphenylacetic acid

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: N,N-dimethyl-formamide; thionyl chloride / toluene / 0.5 h / 40 °C / Inert atmosphere
2: toluene; water / 0.5 h / 0 - 22 °C / Inert atmosphere
3: borane-THF / tetrahydrofuran / 4 h / Inert atmosphere; Reflux
View Scheme
formaldehyd
50-00-0

formaldehyd

4-Methoxyphenethylamine
55-81-2

4-Methoxyphenethylamine

A

4-methoxyphenethyl-dimethylamine
775-33-7

4-methoxyphenethyl-dimethylamine

B

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
With calcium hydride; 5%-palladium/activated carbon In toluene at 30℃; for 16h; Sealed tube;A n/a
B 38 %Spectr.
C15H23NO3

C15H23NO3

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
With hydrogenchloride In water; ethyl acetate for 3h;685 mg
N-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)-ethylamine
121778-75-4

N-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)-ethylamine

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium hydride / mineral oil; tetrahydrofuran / 0.5 h / 0 °C / Inert atmosphere
1.2: 5 h / Inert atmosphere
2.1: hydrogenchloride / water; ethyl acetate / 3 h
View Scheme
N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

2-Chloro-N-(cyclopropylmethyl)-6-morpholinopyrimidine-4-carboxamide

2-Chloro-N-(cyclopropylmethyl)-6-morpholinopyrimidine-4-carboxamide

N-(cyclopropylmethyl)-2-((4-methoxyphenethyl)(methyl)amino)-6-morpholinopyrimidine-4-carboxamide

N-(cyclopropylmethyl)-2-((4-methoxyphenethyl)(methyl)amino)-6-morpholinopyrimidine-4-carboxamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In butan-1-ol at 120℃; for 168h; Inert atmosphere;90%
iodo(trimethylsilyl)methane
4206-67-1

iodo(trimethylsilyl)methane

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

[2-(4-Methoxy-phenyl)-ethyl]-methyl-trimethylsilanylmethyl-amine

[2-(4-Methoxy-phenyl)-ethyl]-methyl-trimethylsilanylmethyl-amine

Conditions
ConditionsYield
In acetonitrile Heating;88%
N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

3-(3-chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepine-2-one
85175-59-3

3-(3-chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepine-2-one

1-[7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-on-3-yl]-3-[N-methyl-N-(2-{4-methoxy-phenyl}-ethyl)-amino]-propane hydrochloride
85175-68-4

1-[7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-on-3-yl]-3-[N-methyl-N-(2-{4-methoxy-phenyl}-ethyl)-amino]-propane hydrochloride

Conditions
ConditionsYield
76.2%
2-methyl-3-[4-(3-chloropropoxy)-phenyl]-7-methoxy-isoquinolin-1(2H)-one
67793-85-5

2-methyl-3-[4-(3-chloropropoxy)-phenyl]-7-methoxy-isoquinolin-1(2H)-one

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

2-Methyl-3-[4-(3-(N-4-methoxyphenethyl-N-methyl-amino)-propoxy)-phenyl]-7-methoxy-isoquinolin-1(2H)-one hydrochloride

2-Methyl-3-[4-(3-(N-4-methoxyphenethyl-N-methyl-amino)-propoxy)-phenyl]-7-methoxy-isoquinolin-1(2H)-one hydrochloride

Conditions
ConditionsYield
In acetone75%
6-methyl-7-[4-(2,3-epoxypropoxy)-phenyl]-1,6-naphthyridin-5(6H)-one
67794-31-4

6-methyl-7-[4-(2,3-epoxypropoxy)-phenyl]-1,6-naphthyridin-5(6H)-one

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

6-Methyl-7-[4-(2-hydroxy-3-(4-methoxyphenethyl-N-methyl-amino)-propoxy)-phenyl]-1,6-naphthyridin-5(6H)-one oxalate
67794-37-0

6-Methyl-7-[4-(2-hydroxy-3-(4-methoxyphenethyl-N-methyl-amino)-propoxy)-phenyl]-1,6-naphthyridin-5(6H)-one oxalate

Conditions
ConditionsYield
61%
ethacrynic acid
58-54-8

ethacrynic acid

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

2-(2,3-dichloro-4-(2-methylenebutanoyl)phenoxy)-N-(4-methoxyphenethyl)-N-methylacetamide

2-(2,3-dichloro-4-(2-methylenebutanoyl)phenoxy)-N-(4-methoxyphenethyl)-N-methylacetamide

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; Inert atmosphere;58%
N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

ethyl acrylate
140-88-5

ethyl acrylate

A

ethyl 2-(7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)acetate

ethyl 2-(7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)acetate

B

ethyl (E)-3-(1-(2-ethoxy-2-oxoethyl)-7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-5-yl)acrylate

ethyl (E)-3-(1-(2-ethoxy-2-oxoethyl)-7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-5-yl)acrylate

Conditions
ConditionsYield
With 2-Pyridone; silver(I) acetate; palladium diacetate; bis(trifluoromethanesulfonyl)amide In dichloromethane at 90℃; for 12h; Sealed tube;A 55%
B 13%
N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

ethyl acrylate
140-88-5

ethyl acrylate

A

ethyl 2-(7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)acetate

ethyl 2-(7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)acetate

B

C20H27NO5

C20H27NO5

Conditions
ConditionsYield
With 2-hydroxypyridin; silver(I) acetate; palladium diacetate; bis(trifluoromethanesulfonyl)amide In dichloromethane at 90℃; for 12h; Sealed tube;A 55%
B 13%
N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

2-(2-chloroethyl)-2,3-dihydro-4-methylpyrido[3,2-f]-1,4-oxazepine-5(4H)-thione
91833-10-2

2-(2-chloroethyl)-2,3-dihydro-4-methylpyrido[3,2-f]-1,4-oxazepine-5(4H)-thione

2,3-dihydro-2-[2-[[2-(4-methoxyphenyl)ethyl]methylamino]ethyl]-4-methylpyrido[3,2-f]-1,4-oxazepine-5(4H)-thione
117427-82-4

2,3-dihydro-2-[2-[[2-(4-methoxyphenyl)ethyl]methylamino]ethyl]-4-methylpyrido[3,2-f]-1,4-oxazepine-5(4H)-thione

Conditions
ConditionsYield
In ethanol Heating;37%
formaldehyd
50-00-0

formaldehyd

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

p-methoxy-N-methylphenethylamine dimer
5839-66-7

p-methoxy-N-methylphenethylamine dimer

Conditions
ConditionsYield
With perchloric acid
1-bromo-2-cyclohexylethane
1647-26-3

1-bromo-2-cyclohexylethane

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

(2-cyclohexyl-ethyl)-(4-methoxy-phenethyl)-methyl-amine

(2-cyclohexyl-ethyl)-(4-methoxy-phenethyl)-methyl-amine

Conditions
ConditionsYield
With ethanol; sodium carbonate at 150℃;
potassium cyanate
590-28-3

potassium cyanate

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

N-(4-methoxy-phenethyl)-N-methyl-urea
92547-62-1

N-(4-methoxy-phenethyl)-N-methyl-urea

Conditions
ConditionsYield
With sulfuric acid
N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

N-methyltyramine
370-98-9

N-methyltyramine

Conditions
ConditionsYield
With hydrogen bromide
N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

(3-chloro-4-methoxy-phenethyl)-methyl-amine
7569-90-6

(3-chloro-4-methoxy-phenethyl)-methyl-amine

Conditions
ConditionsYield
With hydrogenchloride; chlorine
N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

(3-bromo-4-methoxy-phenethyl)-methyl-amine
861199-14-6

(3-bromo-4-methoxy-phenethyl)-methyl-amine

Conditions
ConditionsYield
With hydrogenchloride; bromine
N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

N-(4-methoxy-phenethyl)-N-methyl-β-alanine methyl ester
56100-74-4

N-(4-methoxy-phenethyl)-N-methyl-β-alanine methyl ester

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

Cinnamoyl chloride
102-92-1

Cinnamoyl chloride

herclavine
539-18-4

herclavine

Conditions
ConditionsYield
With potassium hydroxide; benzene
3-bromo-N,N-diethylpropionylamide
5437-82-1

3-bromo-N,N-diethylpropionylamide

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

(+/-)-β-<α.N-Dimethyl-4-methoxy-benzylamino>-N'.N'-diaethyl-propionamid

(+/-)-β-<α.N-Dimethyl-4-methoxy-benzylamino>-N'.N'-diaethyl-propionamid

formaldehyd
50-00-0

formaldehyd

N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

A

p-methoxy-N-methylphenethylamine dimer
5839-66-7

p-methoxy-N-methylphenethylamine dimer

B

compound 48/80
94724-12-6

compound 48/80

Conditions
ConditionsYield
With perchloric acid In water at 90℃; for 4h; Yield given. Yields of byproduct given;
N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

3-(3-chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepine-2-one
85175-59-3

3-(3-chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepine-2-one

7,8-Dimethoxy-3-(3-{[2-(4-methoxy-phenyl)-ethyl]-methyl-amino}-propyl)-1,3-dihydro-benzo[d]azepin-2-one
85175-70-8

7,8-Dimethoxy-3-(3-{[2-(4-methoxy-phenyl)-ethyl]-methyl-amino}-propyl)-1,3-dihydro-benzo[d]azepin-2-one

Conditions
ConditionsYield
at 90 - 95℃; for 2h;
N-methylhomoanisylamine
4091-50-3

N-methylhomoanisylamine

2-Isopropyl-1-[4-(3-bromopropyloxy)benzenesulphonyl]indolizine
114432-17-6

2-Isopropyl-1-[4-(3-bromopropyloxy)benzenesulphonyl]indolizine

{3-[4-(2-Isopropyl-indolizine-1-sulfonyl)-phenoxy]-propyl}-[2-(4-methoxy-phenyl)-ethyl]-methyl-amine
114433-00-0

{3-[4-(2-Isopropyl-indolizine-1-sulfonyl)-phenoxy]-propyl}-[2-(4-methoxy-phenyl)-ethyl]-methyl-amine

Conditions
ConditionsYield
With triethylamine In toluene for 24h; Heating;

4091-50-3Relevant academic research and scientific papers

Structure-Activity Relationship Studies of Pyrimidine-4-Carboxamides as Inhibitors of N-Acylphosphatidylethanolamine Phospholipase D

Mock, Elliot D.,Kotsogianni, Ioli,Driever, Wouter P. F.,Fonseca, Carmen S.,Vooijs, Jelle M.,Den Dulk, Hans,Van Boeckel, Constant A. A.,Van Der Stelt, Mario

, p. 481 - 515 (2021/02/05)

N-Acylphosphatidylethanolamine phospholipase D (NAPE-PLD) is regarded as the main enzyme responsible for the biosynthesis of N-acylethanolamines (NAEs), a family of bioactive lipid mediators. Previously, we reported N-(cyclopropylmethyl)-6-((S)-3-hydroxypyrrolidin-1-yl)-2-((S)-3-phenylpiperidin-1-yl)pyrimidine-4-carboxamide (1, LEI-401) as the first potent and selective NAPE-PLD inhibitor that decreased NAEs in the brains of freely moving mice and modulated emotional behavior [ Mock et al. Nat Chem. Biol., 2020, 16, 667-675 ]. Here, we describe the structure-activity relationship (SAR) of a library of pyrimidine-4-carboxamides as inhibitors of NAPE-PLD that led to the identification of LEI-401. A high-throughput screening hit was modified at three different substituents to optimize its potency and lipophilicity. Conformational restriction of an N-methylphenethylamine group by replacement with an (S)-3-phenylpiperidine increased the inhibitory potency 3-fold. Exchange of a morpholine substituent for an (S)-3-hydroxypyrrolidine reduced the lipophilicity and further increased activity by 10-fold, affording LEI-401 as a nanomolar potent inhibitor with drug-like properties. LEI-401 is a suitable pharmacological tool compound to investigate NAPE-PLD function in vitro and in vivo.

Palladium-Catalyzed C(sp2)-H Olefination of Free Primary and Secondary 2-Phenylethylamines: Access to Tetrahydroisoquinolines

Fan, Shuai,Ding, Yongzheng,Chen, Xiaoxi,Gao, Yuzhen,Fu, Lei,Li, Shangda,Li, Gang

, p. 13003 - 13012 (2019/10/11)

A rapid construction of THIQs by a Pd(II)-catalyzed C(sp2)-H olefination of free primary and secondary 2-phenylethylamines with high step- and atom-economy was reported. Notably, no substituent was required at the α-position to the amino group of the 2-phenylethylamines. The substrate scope was broad, and the reaction could also be applied to generate THIQs from the biologically active molecules such as the drug molecule baclofen and phenylalanine ester.

INHIBITORS OF N-ACYLPHOSPHATIDYLETHANOLAMINE PHOSPHOLIPASE D (NAPE-PLD)

-

, (2019/12/15)

The invention relates to a compound of the formula (I) as novel inhibitor of N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD), and to use thereof for the prophylaxis or treatment of diseases associated with NAPE-PLD. wherein in a ring A, X1 is N, or CR4; X2 is N or CR5; X3 is N or CH; with the proviso that at least one of X1 and X3 is N.

Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase

Winterton, Sarah E.,Capota, Emanuela,Wang, Xiaoyu,Chen, Hong,Mallipeddi, Prema L.,Williams, Noelle S.,Posner, Bruce A.,Nijhawan, Deepak,Ready, Joseph M.

, p. 5199 - 5221 (2018/06/13)

Stearoyl-CoA desaturase (SCD) catalyzes the first step in the conversion of saturated fatty acids to unsaturated fatty acids. Unsaturated fatty acids are required for membrane integrity and for cell proliferation. For these reasons, inhibitors of SCD represent potential treatments for cancer. However, systemically active SCD inhibitors result in skin toxicity, which presents an obstacle to their development. We recently described a series of oxalic acid diamides that are converted into active SCD inhibitors within a subset of cancers by CYP4F11-mediated metabolism. Herein, we describe the optimization of the oxalic acid diamides and related N-acyl ureas and an analysis of the structure-activity relationships related to metabolic activation and SCD inhibition.

NB 06: From a simple lysosomotropic aSMase inhibitor to tools for elucidating the role of lysosomes in signaling apoptosis and LPS-induced inflammation

Blaess, Markus,Bibak, Nelly,Claus, Ralf A.,Kohl, Matthias,Bonaterra, Gabriel A.,Kinscherf, Ralf,Laufer, Stefan,Deigner, Hans-Peter

, p. 73 - 104 (2017/10/17)

Ceramide generation is involved in signal transduction of cellular stress response, in particular during stress-induced apoptosis in response to stimuli such as minimally modified Low-density lipoproteins, TNFalpha and exogenous C6-ceramide. In this paper we describe 48 diverse synthetic products and evaluate their lysosomotropic and acid sphingomyelinase inhibiting activities in macrophages. A stimuli-induced increase of C16-ceramide in macrophages can be almost completely suppressed by representative compound NB 06 providing an effective protection of macrophages against apoptosis. Compounds like NB 06 thus offer highly interesting fields of application besides prevention of apoptosis of macrophages in atherosclerotic plaques in vessel walls. Most importantly, they can be used for blocking pH-dependent lysosomal processes and enzymes in general as well as for analyzing lysosomal dependent cellular signaling. Modulation of gene expression of several prominent inflammatory messengers IL1B, IL6, IL23A, CCL4 and CCL20 further indicate potentially beneficial effects in the field of (systemic) infections involving bacterial endotoxins like LPS or infections with influenza A virus.

Reductive N-methylation of amines with calcium hydride and Pd/C catalyst

Guyon, Carole,Duclos, Marie-Christine,Métay, Estelle,Lemaire, Marc

, p. 3002 - 3005 (2016/07/06)

The methylation of amines by paraformaldehyde in the presence of calcium hydride as a source of hydrogen and palladium on charcoal as catalyst was studied. Depending on the quantity of paraformaldehyde, monomethylated and dimethylated amines were selectively and efficiently prepared in one pot with good yields.

α-Diazo-β-ketonitriles: Uniquely reactive substrates for arene and alkene cyclopropanation

Nani, Roger R.,Reisman, Sarah E.

supporting information, p. 7304 - 7311 (2013/06/27)

An investigation of the intramolecular cyclopropanation reactions of α-diazo-β-ketonitriles is reported. These studies reveal that α-diazo-β-ketonitriles exhibit unique reactivity in their ability to undergo arene cyclopropanation reactions; other similar acceptor-acceptor- substituted diazo substrates instead produce mixtures of C-H insertion and dimerization products. α-Diazo-β-ketonitriles also undergo highly efficient intramolecular cyclopropanation of tri- and tetrasubstituted alkenes. In addition, the α-cyano-α-ketocyclopropane products are demonstrated to serve as substrates for SN2, SN2′, and aldehyde cycloaddition reactions.

Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines

Neustadt, Bernard R.,Liu, Hong,Hao, Jinsong,Greenlee, William J.,Stamford, Andrew W.,Foster, Carolyn,Arik, Leyla,Lachowicz, Jean,Zhang, Hongtao,Bertorelli, Rosalia,Fredduzzi, Silva,Varty, Geoffrey,Cohen-Williams, Mary,Ng, Kwokei

scheme or table, p. 967 - 971 (2009/09/06)

Antagonism of the adenosine A2a receptor offers great promise in the treatment of Parkinson's disease. In the course of exploring pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine A2A antagonists, which led to clinical candidate SCH 420814, we prepared 1,2,4-triazolo[1,5-c]pyrimidines with potent and selective (vs A1) A2a antagonist activity, including oral activity in the rat haloperidol-induced catalepsy model. Structure-activity relationships and plasma levels are described for this series.

Ind2TiMe2-catalyzed addition of methyl- and ethylamine to alkynes

Marcsekova, Klaudia,Wegener, Bernd,Doye, Sven

, p. 4843 - 4851 (2007/10/03)

We describe a very simple hydrogenation-like experimental protocol for the addition of gaseous methyl- and ethylamine to alkynes in the presence of Ind2TiMe2 as the catalyst. For efficient hydroamination reactions it is sufficient to stir a mixture of the alkyne and the catalyst in toluene at temperatures between 80°C (terminal alkynes) and 105°C (internal alkynes) under a constant pressure of 1 atm of the corresponding amine. After subsequent reduction of the initially formed imines, methyl- and ethylamine derivatives are the final products of the described one-pot reaction sequences. In the case of 2-alkyl-1-phenylalkynes as starting materials, biologically interesting 2-phenylethylamine derivatives possessing a small methyl or ethyl substituent at the N atom are easily accessible by the new reaction protocol. Wiley-VCH Verlag GmbH & Co. KGaA, 2005.

Carbamate linkers as latent N-methylamines in solid phase synthesis

Ho, Chih Y.,Kukla, Michael J.

, p. 2799 - 2802 (2007/10/03)

A new linker strategy for solid phase synthesis has been developed. It utilizes LAH reduction of a carbamate connection to Wang resin which results in N-methylamines, a useful functionality in medicinal chemistry.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4091-50-3